Winegrad S
Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia 19104-6085, USA.
Annu Rev Physiol. 1997;59:505-25. doi: 10.1146/annurev.physiol.59.1.505.
Endocardial and coronary vascular endothelial cells release substances that modify the contraction of cardiac myocytes. The major and possibly the sole up-regulating substance is endothelin. Several down-regulating substances are secreted, but none has yet been specifically identified. The relative amounts of up- and down-regulating substances are related to tissue oxygen tension. As pO2 rises, the concentration of up- and down-regulating substances, respectively, increases and decreases. Endothelin increases isometric force and decreases actomyosin ATPase activity thus increasing the economy of conversion of chemical to hydrodynamic energy. Beta-adrenergic agonists increase ATPase activity through an endothelial cell-dependent mechanism, leading to decreased economy. Therefore, two endothelial cell-dependent systems exist for regulating contractile efficiency: One involving endothelin appears to optimize the contraction for efficiency; the other, the beta-adrenergic-mediated system, optimizes for power.
心内膜和冠状血管内皮细胞释放可改变心肌细胞收缩的物质。主要且可能是唯一的上调物质是内皮素。有几种下调物质被分泌出来,但尚未有被明确鉴定的。上调和下调物质的相对量与组织氧张力有关。随着氧分压升高,上调和下调物质的浓度分别增加和降低。内皮素增加等长力并降低肌动球蛋白ATP酶活性,从而提高化学能向流体动力能转化的经济性。β-肾上腺素能激动剂通过内皮细胞依赖机制增加ATP酶活性,导致经济性降低。因此,存在两个内皮细胞依赖系统来调节收缩效率:一个涉及内皮素的系统似乎是为了收缩效率而优化;另一个,β-肾上腺素能介导的系统,则是为了功率而优化。